Bio-pharmaceutical industry uses biomanufacturing technologies to produce vaccines, blood components and proteins. These products have a wide range of application areas from therapeutic use to diagnosis, drug discovery and drug development. Market analysis conducted by BioPlan Associates [1] shows that bio-pharmaceutical industry
has been experiencing an overall consistent growth of 14-15%, and that the global biopharmaceutical
market is expected to reach $341 billion by 2023 (Mordor Intelligence [2]. Unlike traditional pharmaceuticals, biopharmaceutical products are produced using living cells which brings additional manufacturing and optimization challenges. While investment in specialized equipment can address these challenges in part, the effective
management of resources plays a key role in the ultimate success. Langer and Rager [3] emphasize that more than 50% of biopharmaceutical companies have been running into capacity problems resulting from poor resource utilization.